Medicine
Showing 411-420 of 2,402 Results
-
Nancy Cuan, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Nancy Cuan is an internal medicine primary care physician at Stanford Coordinated Care (SCC). SCC is a primary care medicine practice that is a benefit for eligible members of the Stanford University, Stanford Health Care, SLAC and Lucile Packard Children’s Hospital community and their covered adult dependents with ongoing health conditions. More information, including a self-assessment to determine eligibility based on health condition(s) and health insurance, can be found at the Stanford Coordinated Care website.
Prior to joining Stanford Coordinated Care, she had practiced for many years at Santa Clara Valley Medical Center and helped with the resident training program there. She has had experience in working with patients with multiple ongoing medical conditions. -
Christina Curtis
RZ Cao Professor and Professor of Genetics
Current Research and Scholarly InterestsThe Curtis laboratory for Cancer Computational and Systems Biology is focused on the development and application of innovative experimental, computational, and analytical approaches to improve the diagnosis, treatment, and early detection of cancer.
-
Saurabh Dahiya, MD, FACP
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Saurabh Dahiya is a cancer specialist board-certified in internal medicine, hematology, and medical oncology. He serves as Associate Professor of Medicine at Stanford University School of Medicine and Clinical Director of Cell Therapy in the Division of Blood and Marrow Transplantation and Cell Therapy, where he provides patient-centered care for individuals with cancer.
Dr. Dahiya’s research focuses on advancing cellular immunotherapies for hematologic malignancies, including CAR T-cell platforms and next-generation multiantigen targeting strategies for lymphoma. His work aims to address high tumor bulk disease and develop novel cell therapy approaches that enhance durability and response in hematologic cancers. He leads multiple investigator-initiated and industry-sponsored trials in cellular immunotherapy with a focus on translating correlative research insights into improved patient outcomes.
He has authored more than 100 peer-reviewed publications in journals such as The New England Journal of Medicine, Nature Medicine, Journal of Clinical Oncology, Blood, and Blood Advances. Dr. Dahiya serves as Hematology Lead Editor for Critical Reviews in Oncology and Hematology and is an active member of ASH, ASTCT, and ASCO. Before joining Stanford, he was on faculty at the University of Maryland’s Greenebaum Comprehensive Cancer Center, where he helped develop the Cellular Immunotherapy Program.
